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Although self-limited respiratory tract infections caused by Mycoplasma pneumoniae are
well recognized in children and young adults, respiratory involvements and hepatic dysfunc-
tion may occur. The frequency and clinical features of these complications were investigated.
Experimental studies with regard to bacterial superinfection were also carried out. The test
animals which were first infected with Mycoplasmapneumoniae and then with Staphylococcus
aureus showed more extensive bacteriological and pathological changes than those infected
with Staphylococcus aureus only. Liver biopsies performed on three human patients showed
hepatic dysfunction and the histological findings were diagnosed as non-specific reactive
hepatitis in each case.
INTRODUCTION
Mycoplasma pneumoniae (hereafter abbreviated as M. pneumoniae) is well
recognized as the causative organism of respiratory tract infections in children and
young adults. In general, it has been considered that the prognosis for M.
pneumoniae pneumonia is good, and there are few complications. However, organ
systems other than the respiratory may be affected by M. pneumoniae infection.
This infection has caused severe pulmonary complications, including pleural effu-
sions, multilobe distribution, abscess formation, and respiratory failure [1-4]. The
involvement of other organ systems, including the neurologic, gastrointestinal, car-
diovascular, dermatologic, and musculoskeletal, is less well appreciated [5-8].
In adults, the incidence of such complications is generally low. In this paper, we
deal primarily with our data on pulmonary complications and hepatic dysfunction
observed with mycoplasmal pneumonia.
MATERIALS AND METHODS
Pleural Effusion
The incidence of pleural effusion occurring in mycoplasmal pneumonia patients
during the past 16 years was examined. A clinical comparison was made of the pa-
tients with pleural effusion and the patients with no complications.
Bacterial Superinfection
We carried out experimental and clinical studies with regard to bacterial
superinfection. MAC strain cells ofM. pneumoniae, which had been passed through
hamsters, were shake-cultured in PPLO broth. Then the broth culture, containing
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All rights of reproduction in any form reserved.105 to 106 CFU/ml of these cells, was used to infect hamsters by means of nasal
spraying. After leaving these animals undisturbed for a fixed period of time (see
below), a bacterial suspension containing 1.5 x 10 CFU/ml of a clinical isolate of
Staphylococcus aureus (hereafter abbreviated as S. aureus), which had been passed
through the peritoneal cavity of mice, was used to infect the hamsters intranasally.
As a control, other hamsters were infected with the same amount of inoculum of S.
aureus cells only. After a certain time, both groups of these animals were sacrificed
and compared by means of bacteriological and pathological studies.
Following the infection with M. pneumoniae, the animals were infected with S.
aureus after one, two, or three weeks. Differences in the cell counts as a function of
the time of the superinfection were investigated.
The pathological findings, expressed as a score, were compared with the time in-
terval. A score of 1.0 indicated a mild degree of bronchial pneumonia involving a
small number of bronchi and alveoli. A score of 2.0 showed a moderate degree of
bronchial pneumonia with a certain extent of spread. Finally, a score of 3.0 meant
pulmonary findings that showed a severe degree ofbronchial pneumonia with exten-
sive involvement and also abscess formation in some parts.
Bacteriological studies were carried out on the sputum obtained from 137 human
patients diagnosed as having mycoplasmal pneumonia. The patients were divided
into three categories on the basis of their sputum isolates: normal flora, gram-
positive cocci, or gram-negative rods; their clinical pictures were compared.
Viral Superinfection
In Nagasaki, 262 mycoplasmal pneumonia patients were tested for the presence of
viral antibody titers.
In 1980, there had been an epidemic ofmycoplasmal pneumonia in Fukue City on
a small, distant island. At that time, an investigation was carried out on the patients'
serum antibody titers for viruses, and the findings are summarized.
Liver Function Disturbance
After excluding patients with a past history of liver disease and with hepatitis-
associated antigen, 213 patients diagnosed as having mycoplasmal pneumonia were
investigated in terms of hepatic function. A comparison of each patient's clinical
status with respect to the presence or absence of liver function abnormalities was
made. The course taken by GOT and GPT values of the three patients from whom
liver biopsies were taken was compared; also investigated were the histological
changes in the biopsied liver tissues.
RESULTS AND DISCUSSION
Pleural Effusion
Our group found a transient, small amount of pleural effusion in 16 of 460
mycoplasmal pneumonia patients (approximately 4 percent). However, at Nagasaki
in 1979, during a clinical study of an epidemic of mycoplasmal pneumonia, pleural
effusion was observed as a complication in 13 of 113 patients, an incidence of 11.5
percent. Hers and Masurel [9] described small pleural effusions in 10 of 82 patients
with M. pneumoniae pneumonia; Fine et al. [10] reported a figure of 21 percent and
Stenstrom et al. [11]11 percent. Isolation ofM. pneumoniae from pleural fluid was
reported in only one case by Nakao et al. [12].
Pain in the chest was noted in approximately halfofthe patients with pleural effu-
sion, and the clinical course of the infection was also extended.
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The length oftime required for disappearance ofthe patients' pleural effusion was
two weeks or more.
Bacterial Superinfection
Experimental Studies The number of strains of S. aureus in the lungs was found
to be highest in the case of the hamsters that had been infected with S. aureus one
week after infection with M. pneumoniae, as compared with the other animal
groups.
Figure 1 shows a comparison of the cell counts of S. aureus in the hamsters' lungs
as a result of the following procedures: (1) The animals were first infected with M.
pneumoniae by means of a nasal spray, and then, after a one-week period, they were
infected with S. aureus via the nose, and (2) the animals were infected with S. aureus
alone. In the animal group infected with S. aureus alone, the bacterial count was
3.2 x 105 on the second day after the nasal infection, and S. aureus had disap-
peared by the fifth day. Following the infection, it is evident the invading cells were
cleared from the lungs. On the other hand, in the animal group that had first been
infected with M. pneumoniae, the S. aureus cell count in the lungs on the second day
was 1.9 x 106, and the cells of this bacterium could still be detected on the fifth and
sixth days after infection.
In the group of animals that were first infected with M. pneumoniae and then in-
fected with S. aureus, there was a tendency for the pathological findings to be more
severe as compared with the findings in the group infected with S. aureus alone (Fig.
2).
Accordingly, as we have seen, in these animal experiments, hamsters infected with
both M. pneumoniae and S. aureus suffered worse results as hosts in both
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489 OTHER ORGANSbacteriological and pathological terms. Moreover, Liu et al. [13] described an
enhancement by M. pneumoniae of the development of type 1 pneumococcal sep-
ticemia in hamsters experimentally infected with both agents.
Clinical Studies
Gram-positive cocci were isolated from 17, or 12.4 percent, of the human cases,
with S. aureus the most common, since it was detected in the sputum from seven pa-
tients. Gram-negative rods were isolated from 21, or 15.3 percent, ofthe cases; these
included six cases of Hemophilus influenzae and five cases of Klebsiella
pneumoniae. A fever of 38°C or higher, acceleration of the blood sedimentation
rate, leukocytosis, and so on were commonly seen in positive GPC or GNR groups,
and these also showed a tendency for abnormal chest shadows to continue for a
longer period of time.
Viral Superinfection
Thirty-seven percent ofthe cases ofmycoplasmal pneumonia in Nagasaki showed
significant sero-conversion for viruses. Elevated antibody titers against various
viruses (such as RS virus) were detected in 11 of 28 of the patients, or 39.3 percent.
At the same time, 49 patients diagnosed as having non-mycoplasmal pneumonia
were also checked, and 35.4 percent of their sera contained similar elevated levels of
antibodies to viruses. Accordingly, there appeared to be no special tendency for
mycoplasma pneumonia to be accompanied by a higher frequency ofsuperinfection
with viruses. In addition, when the incidence ofserologically verified multiple infec-
tions is discussed, the possibility ofanamnestic serological responses being involved
[7,8,14] must be considered.
Liver Function Disturbance
It was found that 77, or 36.2 percent, of these patients showed some kind of
hepatic function abnormality during the course of the mycoplasmal pneumonia. An
abnormality was detected at initial examination in 59 patients, while 14 first showed
an abnormality at the end of one week, and four others had an abnormality at the
end ofthe second week. During the course oftherapy for the pneumonia, the highest
values detected for liver function abnormalities were 182 for GOT, 242 for GPT,
and 1.4 mg/dl for total bilirubin. The patients with hepatic function abnormalities
showed a tendency to have a higher incidence of abnormalities ofbody temperature,
leucocyte count, and CRP.
In Case 1, after the first week GOT values were elevated and parallel to GPT
values. In the other two cases, however, GOT values gradually decreased and
became normalized. GPT increased in Case 1 in the first week, and increased in Case
3 in the third week, but GPT values had returned to normal in all three patients by
the fourth week. The pathological findings in the liver biopsies showed a certain
degree of difference, but in all cases the diagnosis was non-specific reactive
hepatitis. The structure of the lobules of the liver was seen to be normal, although
there was a mild degree of lymphocyte infiltration in Glisson's capsule, and there
was not much severe degeneration or necrosis ofthe hepatic cells. Nevertheless, scat-
tered single-cell necrosis and focal necrosis could be seen, and these findings are in-
dicative of so-called non-specific reactive hepatitis. Fraley et al. [2] also reported
that the liver showed patchy cell necrosis and inflammatory cell infiltrates.
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CONCLUSION
1. Data were presented on the pleural effusion, bacterial and viral superinfec-
tions, and hepatic dysfunction that have been found to accompany mycoplasmal
infection.
2. The incidence ofoccurrence ofthe above-mentioned complications in the case
of mycoplasmal pneumonia was as follows: pleural effusion, 4 percent; superinfec-
tions by bacteria, 28 percent; viral superinfections, 37 percent; and hepatic dysfunc-
tion, 36 percent.
3. In the patients who experienced these complications, there was a tendency for
the clinical symptoms to be severe and for the course of recovery to be delayed.
4. Experiments were performed on mixed infections of M. pneumoniae and S.
aureus in hamsters. When the animals were first infected with M. pneumoniae and
then with S. aureus, both the bacteriological and pathological changes were more ex-
tensive than in the case of animals infected with S. aureus only.
5. Liver biopsies were performed on three human patients showing complica-
tions of hepatic dysfunction. Observations of the excised liver tissues resulted in a
diagnosis of non-specific reactive hepatitis for each case.
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